Biomedical Engineering Reference
In-Depth Information
Further understanding of the mechanisms involved in drug delivery
will result in improved drug delivery systems tailor-made for a
particular application.
Acknowledgments
The authors wish to thank Dr. Micha Fridman from the TAU School
of Chemistry for his help in the presentation of the polysaccharide
chemical structures.
References
1. Petros RA, DeSimone JM (2010) Strategies in the design of nanoparticles
for therapeutic applications.
Nat Rev Drug Discov
9: 615-627.
2. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, et al. (2007)
Nanocarriers as an emerging platform for cancer therapy.
Nat
Nanotechnol
2: 751-760.
3. Peer D, Margalit R (2004) Tumor-targeted hyaluronan nanoliposomes
increase the antitumor activity of liposomal doxorubicin in syngeneic
and human xenograft mouse tumor models.
Neoplasia
6: 343-353.
4. Sinha VR, Kumria R (2001) Polysaccharides in colon-specific drug
delivery.
Int J Pharm
224: 19-38.
5. Muzzarelli R (1973) Chitosan. In: Muzzarelli, editor.
Natural Chelating
Polymers
: Pergamon Press, Oxford pp. 144-176.
6. Alpar HO, Somavarapu S, Atuah KN, Bramwell VW (2005) Biodegradable
mucoadhesive particulates for nasal and pulmonary antigen and DNA
delivery.
Adv Drug Deliv Rev
57: 411-430.
7. Paolicelli P, de la Fuente M, Sanchez A, Seijo B, Alonso MJ (2009)
Chitosan nanoparticles for drug delivery to the eye.
Expert Opin Drug
Deliv
6: 239-253.
8. Takeuchi H, Yamamoto H, Kawashima Y (2001) Mucoadhesive
nanoparticulate systems for peptide drug delivery.
Adv Drug Deliv Rev
47: 39-54.
9. Valenta C, Auner BG (2004) The use of polymers for dermal and
transdermal delivery.
Eur J Pharm Biopharm
58: 279-289.
10. Sashiwa H, Saimoto H, Shigemasa Y, Ogawa R, Tokura S (1990) Lysozyme
susceptibility of partially deacetylated chitin.
Int J Biol Macromol
12:
295-296.
11. Muzzarelli R, Baldassarre V, Conti F, Ferrara P, Biagini G, et al. (1988)
Biological activity of chitosan: ultrastructural study.
Biomaterials
9:
247-252.
Search WWH ::
Custom Search